General Nurse Practitioner News

NP

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Blumer R et al. - Treatment for 3 months with a NRTI-containing, but not a NRTI-sparing, regimen resulted in a 25% decrease in insulin-mediated glucose disposal and a 22% increase in fasting lipolysis. In the absence of discernable changes in body composition, NRTI may directly affect glucose metabolism, the mechanism by which remains to be elucidated

Related Articles

Immune control of HIV-1 infection after therapy interruption: immediate versus deferred antiretroviral therapy
BMC Infectious Diseases, 10/20/09    Relevance Score: 67%

Interleukin-2 Therapy in Patients with HIV Infection
New England Journal of Medicine, 10/15/09    Relevance Score: 67%

Epidemiology and therapy of pain and depression during HIV and AIDS
Schmerz, 10/01/09    Relevance Score: 67%

Association of Race, Substance Abuse, and Health Insurance Coverage With Use of Highly Active Antiretroviral Therapy Among HIV-Infected Women, 2005
American Journal of Public Health, 11/16/09    Relevance Score: 66%

Simplification of Antiretroviral Therapy with Tenofovir-Emtricitabine or Abacavir-Lamivudine
Clinical Infectious Diseases, 10/28/09    Relevance Score: 66%

Today in Clinical Pharmacology...keeping you current

Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia
Haematologica, 12/18/09

Nilotinib As Front-Line Treatment for Patients With Chronic Myeloid Leukemia in Early Chronic Phase
Journal of Clinical Oncology, 12/18/09

New therapies for the treatment of type 2 diabetes: an update
European Diabetes Nursing, 12/18/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address